Kalaris Therapeutics Inc operates as a pharmaceutical company. The Company specializes in the development of novel cell therapies with a focus on restoring natural immunity against life-threatening virus-associated diseases in patients with severely weakened immune systems.
Name / Ticker | Price | Zen Rating |
---|---|---|
$47.20 | A | |
$8.30 | A | |
$65.30 | A |